These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 16510589

  • 1. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA.
    Cancer Res; 2006 Mar 01; 66(5):2691-9. PubMed ID: 16510589
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.
    Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M, Yu DY.
    Cancer Res; 2001 Feb 01; 61(3):984-90. PubMed ID: 11221894
    [Abstract] [Full Text] [Related]

  • 3. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
    Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM.
    Cancer Res; 1998 Dec 01; 58(23):5500-6. PubMed ID: 9850086
    [Abstract] [Full Text] [Related]

  • 4. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 5. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM, Shackleford GM.
    Oncogene; 1997 Jun 19; 14(24):2985-9. PubMed ID: 9205106
    [Abstract] [Full Text] [Related]

  • 6. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.
    Cancer Res; 2007 Sep 15; 67(18):8671-81. PubMed ID: 17875707
    [Abstract] [Full Text] [Related]

  • 7. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackleford GM, MacArthur CA.
    Oncogene; 1998 Nov 26; 17(21):2711-7. PubMed ID: 9840935
    [Abstract] [Full Text] [Related]

  • 8. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M, Akahane T, Buck T, Yoshiji H, Gomez DE, Schoeffner DJ, Okajima E, Harris SR, Bunce OR, Thorgeirsson SS, Thorgeirsson UP.
    Carcinogenesis; 2004 Sep 26; 25(9):1735-46. PubMed ID: 15166086
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM, Welsh J.
    Carcinogenesis; 2004 Dec 26; 25(12):2361-72. PubMed ID: 15333467
    [Abstract] [Full Text] [Related]

  • 10. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Hofmann UB, Eggert AA, Blass K, Bröcker EB, Becker JC.
    Cancer Res; 2003 Dec 01; 63(23):8221-5. PubMed ID: 14678978
    [Abstract] [Full Text] [Related]

  • 11. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 12. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
    Easter SL, Mitchell EH, Baxley SE, Desmond R, Frost AR, Serra R.
    PLoS One; 2014 May 01; 9(11):e113247. PubMed ID: 25401739
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
    Szabova L, Chrysovergis K, Yamada SS, Holmbeck K.
    Oncogene; 2008 May 22; 27(23):3274-81. PubMed ID: 18071307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
    Witty JP, Lempka T, Coffey RJ, Matrisian LM.
    Cancer Res; 1995 Apr 01; 55(7):1401-6. PubMed ID: 7882342
    [Abstract] [Full Text] [Related]

  • 18. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
    Cardillo MR, Di Silverio F, Gentile V.
    Anticancer Res; 2006 Apr 01; 26(2A):973-82. PubMed ID: 16619495
    [Abstract] [Full Text] [Related]

  • 19. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland.
    Szabova L, Yamada SS, Birkedal-Hansen H, Holmbeck K.
    J Cell Physiol; 2005 Oct 01; 205(1):123-32. PubMed ID: 15895410
    [Abstract] [Full Text] [Related]

  • 20. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA, Troyer KL, Lee DC.
    Oncogene; 2000 Jun 29; 19(28):3193-9. PubMed ID: 10918574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.